Serum hepcidin and interleukin-6 in systemic lupus erythematosus patients: crucial factors for correction of anemia
Abstract Background The incidence rate of anemia of chronic disease (ACD) in systemic lupus erythematosus (SLE) ranges between 30 and 80%. Serum iron is the main regulator of hepatic hepcidin production. Interleukin-6 (IL-6) upregulates hepcidin expression. The aim of this study is to compare betwee...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-07-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-020-00006-5 |